Show simple item record

Inhibition of MYC by the SMARCB1 tumor suppressor

dc.contributor.authorWeissmiller, April M.
dc.contributor.authorWang, Jing
dc.contributor.authorLorey, Shelly L.
dc.contributor.authorHoward, Gregory C.
dc.contributor.authorMartinez, Ernest
dc.contributor.authorLiu, Qi
dc.contributor.authorTansey, William P.
dc.date.accessioned2020-04-07T18:55:45Z
dc.date.available2020-04-07T18:55:45Z
dc.date.issued2019-05-01
dc.identifier.citationWeissmiller, A. M., Wang, J., Lorey, S. L., Howard, G. C., Martinez, E., Liu, Q., & Tansey, W. P. (2019). Inhibition of MYC by the SMARCB1 tumor suppressor. Nature communications, 10(1), 2014. https://doi.org/10.1038/s41467-019-10022-5en_US
dc.identifier.issn2041-1723
dc.identifier.urihttps://ir.vanderbilt.edu/xmlui/handle/1803/9902
dc.description.abstractSMARCB1 encodes the SNF5 subunit of the SWI/SNF chromatin remodeler. SNF5 also interacts with the oncoprotein transcription factor MYC and is proposed to stimulate MYC activity. The concept that SNF5 is a coactivator for MYC, however, is at odds with its role as a tumor-suppressor, and with observations that loss of SNF5 leads to activation of MYC target genes. Here, we reexamine the relationship between MYC and SNF5 using biochemical and genome-wide approaches. We show that SNF5 inhibits the DNA-binding ability of MYC and impedes target gene recognition by MYC in cells. We further show that MYC regulation by SNF5 is separable from its role in chromatin remodeling, and that reintroduction of SNF5 into SMARCB1-null cells mimics the primary transcriptional effects of MYC inhibition. These observations reveal that SNF5 antagonizes MYC and provide a mechanism to explain how loss of SNF5 can drive malignancy.en_US
dc.description.sponsorshipWe thank Scott Hiebert for his critical contributions to the study and the Vanderbilt University Chemical Synthesis Core for synthesis of the dTag47 molecule. This work was supported by grants from St. Baldrick's Foundation, Alex's Lemonade Stand Foundation, the Edward P. Evans Foundation, the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, and grant CA200709 from the National Institutes of Health (to W.P.T.); The Rally Foundation for Childhood Cancer Research Fellowship, Open Hands Overflowing Hearts co-funded Research Fellowship, and the American Association for Cancer Research Basic Cancer Research Fellowship to A.M.W.; The Vanderbilt Ingram Cancer Center Support grant (NIH: CA68485); and by CTSA award UL1TR002243 from the National Center for Advancing Translational Sciences.en_US
dc.language.isoen_USen_US
dc.publisherNature Communicationsen_US
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing,adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder
dc.source.urihttps://www.nature.com/articles/s41467-019-10022-5.pdf
dc.subjectSWI/SNF COMPLEXen_US
dc.subjectC-MYCen_US
dc.subjectBAF COMPLEXESen_US
dc.subjectTRANSCRIPTIONen_US
dc.subjectCHROMATINen_US
dc.subjectARRESTen_US
dc.subjectTUMORIGENESISen_US
dc.subjectACTIVATIONen_US
dc.subjectINITIATIONen_US
dc.subjectINTERACTSen_US
dc.titleInhibition of MYC by the SMARCB1 tumor suppressoren_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41467-019-10022-5


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record